STAT

Vaccines don’t work against some viruses. CRISPR might one day fix that

Vaccines don't work against several viral diseases. Now scientists are trying rescue one of the oldest biotechnologies with one of the newest — #CRISPR.
Electron micrograph of a human B cell

Two centuries isn’t a bad run for a medical technology. But while vaccination has prevented hundreds of millions of deaths since 1796, when Edward Jenner inoculated a boy with cowpox to prevent smallpox, there’s clearly room for improvement: Vaccines are risky or ineffective in people with compromised immune systems, they don’t even exist for several viral diseases, and flu vaccines, in particular, often fail in the elderly.

All of which gave scientists in half a dozen labs the same idea: Rescue one of the oldest biotechnologies with one of the newest — CRISPR.

In one study published last month, another posted to the preprint

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks